• Je něco špatně v tomto záznamu ?

Impact of centre volume on atrial fibrillation ablation outcomes in Europe: a report from the ESC EHRA EORP Atrial Fibrillation Ablation Long-Term (AFA LT) Registry

VP. Vassilikos, ED. Pagourelias, C. Laroche, C. Blomström-Lundqvist, J. Kautzner, AP. Maggioni, L. Tavazzi, N. Dagres, J. Brugada, M. Stühlinger, E. Arbelo, AFA LT registry investigators group

. 2021 ; 23 (1) : 49-58. [pub] 20210127

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc21026172

AIMS: The aim of the study was to investigate differences in clinical outcomes and complication rates among European atrial fibrillation (AF) ablation centres related to the volume of AF ablations performed. METHODS AND RESULTS: Data for this analysis were extracted from the ESC EHRA EORP European AF Ablation Long-Term Study Registry. Based on 33rd and 67th percentiles of number of AF ablations performed, the participating centres were classified into high volume (HV) (≥ 180 procedures/year), medium volume (MV) (<180 and ≥74/year), and low volume (LV) (<74/year). A total of 91 centres in 26 European countries enrolled in 3368 patients. There was a significantly higher reporting of cardiovascular complications and stroke incidence in LV centres compared with HV and MV (P = 0.039 and 0.008, respectively) and a lower success rate after AF ablation (55.3% in HV vs. 57.2% in LV vs. 67.4% in MV centres, P < 0.001), despite lower CHA2DS2-VASc score of patients, enrolled in LVs and less complex ablation techniques used. Adjustments of confounding factors (including type of AF ablation) led to elimination of these differences. CONCLUSION: Low-volume centres tended to present slightly higher cardiovascular complications' and stroke incidence and a lower unadjusted success rate after AF ablation, despite the fact that ablation procedures and patients were of lower risk compared with MV and HV centres. On the other hand, adjusted overall complication and recurrence rates were non-significantly different among different volume centres, a fact reflecting the heterogeneity of patient and procedural profiles, and a counterbalance between expertise and risk level among participating centres.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21026172
003      
CZ-PrNML
005      
20211026133139.0
007      
ta
008      
211013s2021 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1093/europace/euaa236 $2 doi
035    __
$a (PubMed)33141150
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Vassilikos, Vassilios P $u Third Department of Cardiology, Hippokrateion General Hospital, Medical School, Aristotle University of Thessaloniki, 49 Konstantinoupoleos str, 54642 Thessaloniki, Greece
245    10
$a Impact of centre volume on atrial fibrillation ablation outcomes in Europe: a report from the ESC EHRA EORP Atrial Fibrillation Ablation Long-Term (AFA LT) Registry / $c VP. Vassilikos, ED. Pagourelias, C. Laroche, C. Blomström-Lundqvist, J. Kautzner, AP. Maggioni, L. Tavazzi, N. Dagres, J. Brugada, M. Stühlinger, E. Arbelo, AFA LT registry investigators group
520    9_
$a AIMS: The aim of the study was to investigate differences in clinical outcomes and complication rates among European atrial fibrillation (AF) ablation centres related to the volume of AF ablations performed. METHODS AND RESULTS: Data for this analysis were extracted from the ESC EHRA EORP European AF Ablation Long-Term Study Registry. Based on 33rd and 67th percentiles of number of AF ablations performed, the participating centres were classified into high volume (HV) (≥ 180 procedures/year), medium volume (MV) (<180 and ≥74/year), and low volume (LV) (<74/year). A total of 91 centres in 26 European countries enrolled in 3368 patients. There was a significantly higher reporting of cardiovascular complications and stroke incidence in LV centres compared with HV and MV (P = 0.039 and 0.008, respectively) and a lower success rate after AF ablation (55.3% in HV vs. 57.2% in LV vs. 67.4% in MV centres, P < 0.001), despite lower CHA2DS2-VASc score of patients, enrolled in LVs and less complex ablation techniques used. Adjustments of confounding factors (including type of AF ablation) led to elimination of these differences. CONCLUSION: Low-volume centres tended to present slightly higher cardiovascular complications' and stroke incidence and a lower unadjusted success rate after AF ablation, despite the fact that ablation procedures and patients were of lower risk compared with MV and HV centres. On the other hand, adjusted overall complication and recurrence rates were non-significantly different among different volume centres, a fact reflecting the heterogeneity of patient and procedural profiles, and a counterbalance between expertise and risk level among participating centres.
650    12
$a fibrilace síní $x diagnóza $x epidemiologie $x chirurgie $7 D001281
650    12
$a katetrizační ablace $x škodlivé účinky $7 D017115
650    _2
$a lidé $7 D006801
650    _2
$a recidiva $7 D012008
650    _2
$a registrace $7 D012042
650    _2
$a rizikové faktory $7 D012307
650    _2
$a výsledek terapie $7 D016896
651    _2
$a Evropa $7 D005060
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Pagourelias, Efstathios D $u Third Department of Cardiology, Hippokrateion General Hospital, Medical School, Aristotle University of Thessaloniki, 49 Konstantinoupoleos str, 54642 Thessaloniki, Greece
700    1_
$a Laroche, Cécile $u EURObservational Research Programme (EORP), European Society of Cardiology, Sophia-Antipolis, France
700    1_
$a Blomström-Lundqvist, Carina $u Department of Medical Science and Cardiology, Uppsala University, Uppsala, Sweden
700    1_
$a Kautzner, Josef $u Department of Cardiology, Institute for Clinical and Experimental Medicine (ΙΚΕΜ), Prague, Czech Republic
700    1_
$a Maggioni, Aldo P $u EURObservational Research Programme (EORP), European Society of Cardiology, Sophia-Antipolis, France $u ANMCO Research Centre, Florence, Italy
700    1_
$a Tavazzi, Luigi $u Cardiovascular Department, Maria Cecilia Hospital, GVM Care & Research, Cotignola, Italy
700    1_
$a Dagres, Nikolaos $u Department of Electrophysiology, Heart Center Leipzig at University of Leipzig, Leipzig, Germany
700    1_
$a Brugada, Josep $u Hospital Clínic Pediatric Arrhythmia Unit, Cardiovascular Institute, Hospital Sant Joan de Déu University of Barcelona, Barcelona, Spain
700    1_
$a Stühlinger, Markus $u Clinic of Internal Medicine III/Cardiology, Medical University of Innsbruck, Innsbruck, Austria
700    1_
$a Arbelo, Elena $u Department of Cardiology, Cardiovascular Institut, Hospital Clinic de Barcelona, Universitat de Barcelona, Barcelona, Spain $u Instit d'Investigació August Pi i Sunyer (IDIBAPS), Barcelona, Spain $u Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain
710    2_
$a AFA LT registry investigators group
773    0_
$w MED00149837 $t Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology $x 1532-2092 $g Roč. 23, č. 1 (2021), s. 49-58
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33141150 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20211013 $b ABA008
991    __
$a 20211026133145 $b ABA008
999    __
$a ok $b bmc $g 1715013 $s 1146679
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 23 $c 1 $d 49-58 $e 20210127 $i 1532-2092 $m Europace $n Europace $x MED00149837
LZP    __
$a Pubmed-20211013

Najít záznam

Citační ukazatele

Možnosti archivace